';
Tags Posts tagged with "ODP"

ODP

This webinar is for all interested stakeholders. Presentation topics from Dr. Rabea Khadimi and Dr. Antonie Auguste will include holiday gatherings, Norovirus, food safety, and more. Sessions are assigned by region. Please register for the session corresponding to your region below.

Presenters

Rabea Khedimi, MD

Rabea Khedimi, MD, is a faculty member and ID Specialty Physician with UPMC/ID Connect. Rabea served as the Chief of the Infection Prevention and Control at the NYC Health + Hospitals/Elmhurst, and as Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. She has been involved in the management of patients with suspected Infectious Diseases since she joined the Mount Sinai School of Medicine. Dr. Khedimi completed her internal medicine training at the Icahn School of Medicine at Mount Sinai/Elmhurst and her Infectious Diseases Fellowship training at Mount Sinai School of Medicine. Her career as a Clinician-Educator and Clinician-Administrator includes Leadership roles at the Mount Sinai School of Medicine/Elmhurst Hospital in Queens and Montefiore/Albert Einstein College of Medicine in the Bronx. She was an Assistant Professor of Medicine and an Infectious Disease Attending at Montefiore Medical Center. She also served as a Co-Director of Microbiology/Infectious Diseases courses at Albert Einstein College of Medicine.

Dr. Khedimi has experience in both teaching and providing clinical care to patients with HIV, Hepatitis B and C, STDs, and other infectious diseases. She also has expertise in Infection Control and was most recently the Chief of the Infection Prevention and Control Department at the NYC HHC/Elmhurst Hospital.

Antonie J. Auguste, MD, MPH

Dr Antonie J. Auguste has been recognized as an IDSA Fellow (FIDSA). Dr. Auguste serves the ID Division at UPMC/ID Connect. Her primary role focuses on providing inpatient Infectious Diseases consultation services via the Infectious Diseases Telemedicine service to multiple additional sites across telemedicine sites and rounding on the in-person services at UPMC Presbyterian Hospital. Additionally, she provides telemedicine Infection Prevention and Control consultation to various telemedicine sites. Antonie earned her medical degree from the State University of New York Upstate Medical University at Syracuse and completed her residency in Internal Medicine and Fellowship in Infectious Disease at the State University of New York at Stony Brook University Hospital and School of Medicine. She obtained her MPH degree from Columbia University School of Public Health, and a BA degree in biology from Columbia University.

Kate Gass, RN, BSN, CIC

With a varied background in clinical nursing and nursing management, Kate has spent time working in intensive care, emergency department, and the cardiac cath lab. Earning her ASN from Butler County College and BSN from Clarion University of Pennsylvania, she is certified as a cardiac invasive specialist and is also certified by the Board of Infection Control and Epidemiology.

Register

Registration is required to participate. Sessions are assigned by region. Select the appropriate session below to register.

Western Region
Tuesday, December 6 from 1:00 pm – 2:30 pm

Northeast Region
Wednesday, December 7 from 1:00 pm – 2:30 pm

Central Region
Wednesday, December 14 from 1:00 pm – 2:30 pm

Southeast Region
Thursday, December 15 from 1:00 pm – 2:30 pm

ODP Announcement 22-116 releases updated protocols for the Health Risk Screening Tool. The accompanying document is an update to the previously released protocol for HRST. It contains information regarding expectations, timelines, and reflects changes in the process since the initial protocol was distributed. Additionally, it provides guidance regarding roles and responsibilities for those expected to use the tool.

Assistance can also be obtained by contacting HRST support and HRST Assistance.

ODP Announcement 22-114 reports that the Office of Developmental Programs (ODP) contracts with Temple University Harrisburg to deliver the ODP Certified Investigator Program. ODP and Temple University are conducting Certified Investigator Friday Forums. These forums are an opportunity for current Certified Investigators and other interested parties to receive up-to-date information about the incident investigation process. See the announcement for full details.

Concept of important day, reminder, organizing time and schedule - red pen marking day of the month on a calendar

Power up your December with the Self Advocacy Power Network for All (SAPNA)!

SAPNA is a project of the PA Office of Developmental Programs (ODP), managed by Self Advocates United as 1 (SAU1). See the flyer for info on December events. Each item below is linked to the event, or you can join from the SAU1 Events Calendar.


Friday, December 2, 2022
10:30 am – 12:30 pm
Let’s Talk About Your Vision for YOUR Everyday Life

  • What do YOU want in your life?
  • How do you make it happen?
  • Who can help?
  • Learn how to plan for, and get, the life YOU want!

Monday, December 5, 2022
10:00 am – 12:00 pm
Let’s Speak Up!

  • Do you know your rights?
  • Are you getting what you want and need?
  • Join us to learn all about speaking up.
  • Tell us ways YOU speak up!

Monday, December 12
1:00 pm – 3:00 pm
All About Jobs!

  • Your rights
  • Planning to work
  • Finding a job
  • Keeping your job
  • Workplace accommodations
  • ODP-funded supports
  • Other supports
  • Work and your benefits

Friday, December 16
11:30 am – 12:30 pm
Power Talk With ODP!

  • Join us to talk about services, issues, and COVID.
  • Get the answers you need to speak up, and live your life, your way.
  • Call or email us by December 1 with your questions and comments,, and we will share them with ODP!

ODP Announcement 22-113 is to provide guidance and a timeline for the implementation requirement of the 2022 Online Medication Administration Training Course and manual. It is also to announce the discontinuation of the 2004 paper course and paper examinations, effective on January 1, 2024.

All Medication Administration trainers are now required to take the new 2022 online Medication Administration Training Course. Existing trainers who have not been certified through the new course are required to take the 2022 online course when their certification expires. Both new and existing trainers may continue to monitor students and practicum observers.

If you have any questions regarding the new Medication Administration Training Course, please email the Help Desk.

ODP Announcement 22-112 informs all interested parties that on October 31, 2022, the Department submitted Pennsylvania’s Statewide Transition Plan to the Centers for Medicare & Medicaid Services (CMS). CMS is responsible for reviewing the Statewide Transition Plan to ensure all federal regulatory requirements are met. During the review process, CMS may request that technical changes be made to the plan. When this occurs, CMS usually includes a summary of changes made with the final approval letter. The Department will notify all interested stakeholders when CMS has given its approval and will make the approved version available at that time.

The Statewide Transition Plan may be viewed here. Questions about the Statewide Transition Plan or this communication should be sent electronically.

ODP Announcement 22-111 reminds providers that any regulation that requires completion of 24 hours of training related to job skills and knowledge each year, as well as any regulations that require the provision of training that encompasses the six areas required by regulation, are in full effect. Providers must comply with these requirements.

The Office of Developmental Programs (ODP) recognizes that providers may still be struggling to meet the 24-hour training requirements due to the prevalence of infectious or communicable diseases and continued workforce insufficiency; as such, the following guidance will be applied for training years that end in calendar year 2023:

  • Any training provided that is specific to the mitigation of risk related to infectious and communicable disease may be counted towards the 24-hour training requirements required by regulation. Such training includes, but is not necessarily limited to:
    • Social distancing;
    • Personal protective equipment use (donning, doffing, fit testing);
    • Contact tracing and notifications;
    • Mask, face covering, or face shield use;
    • Cleaning and disinfection practices;
    • Screening for signs and symptoms of infectious disease;
    • Reporting procedures related to signs and symptoms of infectious disease;
    • Notification processes due to infectious reportable infectious disease;
    • Characteristics and methods of transmission of infectious disease;
    • COVID-19 transmission risk by pre-symptomatic and asymptomatic individuals;
    • Safe and healthy work practices and infection control measures;
    • Supporting individuals to engage in mask wearing, social distancing, etc.;
    • Vaccine safety, efficacy, and access;
    • Set up and use of technology in providing remote service delivery or supporting individuals to connect with friends and family;
    • Remote monitoring;
    • Use of the Supports Coordinator Check-In for Well-Being Tool;
    • Engaging in meaningful conversations during check-ins;
    • SC Individual transition guide;
    • Transition discussion and resources video; and
    • Reviewing Centers for Disease Control (CDC) and state or local guidelines and trends.
  • Any component of a department-approved Medication Administration Course.

Licensed Providers may self-assess regulatory compliance using ODP’s Inspection Scoresheets or Provider Self-Assessment Forms. If a provider identifies areas of noncompliance while completing a self-assessment, provided those noncompliance areas have been corrected, licensing staff will not identify those areas as noncompliant. Violations identified and subsequently corrected through the self-assessment process will not be cited on a Licensing Inspection Summary.

Please contact the appropriate ODP Regional Program Office or the Department’s Regulatory Administration Unit with any questions about this guidance.